Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.25 USD | +0.86% | -2.48% | +205.56% |
May. 15 | Eliem Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 11 | Sector Update: Health Care Stocks Softer Late Afternoon | MT |
Financials (USD)
Sales 2022 | - | Sales 2023 | - | Capitalization | 74.45M |
---|---|---|---|---|---|
Net income 2022 | -45M | Net income 2023 | -35M | EV / Sales 2022 | - |
Net cash position 2022 | 123M | Net cash position 2023 | 106M | EV / Sales 2023 | - |
P/E ratio 2022 |
-2.13
x | P/E ratio 2023 |
-2.07
x | Employees | 10 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 74.82% |
1 day | +0.86% | ||
1 week | -2.48% | ||
Current month | +16.36% | ||
1 month | +97.37% | ||
3 months | +215.90% | ||
6 months | +224.80% | ||
Current year | +205.56% |
Managers | Title | Age | Since |
---|---|---|---|
Valerie Morisset
FOU | Founder | 55 | 18-10-17 |
Andrew Levin
CEO | Chief Executive Officer | 47 | 18-10-17 |
Emily Pimblett
AUD | Comptroller/Controller/Auditor | 40 | 21-02-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Liam Ratcliffe
BRD | Director/Board Member | 60 | 19-09-30 |
Adam Rosenberg
BRD | Director/Board Member | 54 | 20-09-30 |
Andrew Levin
CEO | Chief Executive Officer | 47 | 18-10-17 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-17 | 8.25 | +0.86% | 318,649 |
24-05-16 | 8.18 | +2.38% | 134,901 |
24-05-15 | 7.99 | -2.44% | 202,767 |
24-05-14 | 8.19 | -2.62% | 163,464 |
24-05-13 | 8.41 | -0.59% | 114,451 |
Delayed Quote Nasdaq, May 17, 2024 at 04:00 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
+205.56% | 231M | |
+9.42% | 115B | |
+11.84% | 106B | |
-1.05% | 21.96B | |
-14.15% | 21.84B | |
-5.29% | 19.21B | |
-4.16% | 18.08B | |
-38.29% | 17.71B | |
+7.99% | 14.32B | |
+36.24% | 12.42B |
- Stock Market
- Equities
- ELYM Stock